Sangeetha Sundaramoorthy has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sangeetha Sundaramoorthy, a member of the promoter group of Lotus Eye Hospital and Institute Limited, has submitted a disclosure under Regulation 10(5) of the SEBI Takeover Regulations. This regulation pertains to intimation of inter se transfers of shares among promoters and promoter group members. No specific details regarding the number of shares transferred, the parties involved, or the resulting shareholding changes have been disclosed in the filing summary. The disclosure is a routine regulatory compliance filing.
This is a routine inter se transfer disclosure within the promoter group and is unlikely to have a material impact on the stock price. It signals internal reshuffling of shareholding among promoter family members rather than any change in overall promoter control.